Scorecard
| Current Price | Overvalued | |
| Yield (%) – Higher is better Current Yield: 3.18% Industry Average: 3.31% | ||
| Dividend Growth (%) – Higher is better Dividend Growth: 5.81% Industry Average: 6.41% | ||
| Returns (%) – Higher is better Returns: 16.98% Industry Average: 12.77% | ||
| Free Cash Flow Payout Ratio (%) – Lower is better FCFPR: 67.03% Industry Average: 51.49 | ||
ABBVIE INC.
(XNYS:ABBV)
Industry: Pharmaceuticals
| Price | Change (Daily) |
| $ 217.72 | $ -0.91 |
Dividend
Annual Dividend | Annual Yield |
$ 6.92 | 3.18 % |
Dividend Streak | 5 Year Average |
13 year(s) | 3.82 % |
Fair Price
Current Stock price is considered: Overvalued
| Current Price ● $ 217.72 |
| Less Than $154.17 | $154.17 – $209.49 | More Than $209.49 |
| Undervalued | Fair Price | Overvalued |
Using average Dividend Yield for stock valuation. Learn about this method for Fair Price analysis HERE.
Growth
Dividend Growth Rate
1 Year | 3 Year | 5 Year |
5.81 % | 5.17 % | 6.83 % |
| 2021 | 2022 | 2023 | 2024 | 2025 |
| $ 5.20 | $ 5.64 | $ 5.92 | $ 6.20 | $ 6.56 |
Price Return
1 Year | 5 Year | CAGR 5 Years |
$ 31.61 16.98 % | $ 104.52 | 13.98 % |